Histone Deacetylases Function in the Control of Early Hematopoiesis and Erythropoiesis
Abstract
:1. Introduction
2. Role of HAT and HDAC in the Regulation of Gene Expression though Histone Acetylation
3. Biological Function of Acetylation/Deacetylation of Non-Histone Substrates
4. HDACs in Hematopoiesis
4.1. HDAC Role in the Maintenance of Hematopoietic Stem Cell (HSC)
4.2. Role of HDACs during Erythropoiesis
4.2.1. HDACs and the Regulation of γ-Globin Gene Expression
4.2.2. Class I HDACs in Terminal Erythroid Differentiation
4.2.3. HDAC Class II during Erythroid Differentiation
5. Conclusions
Member | Related Cellular Functions | Substrates |
---|---|---|
HDAC1 |
| EKLF (K302) Histones H3 and H4 TAF9 |
HDAC2 |
| |
HDAC3 |
| Histones H3 and H4 |
HDAC5 |
| p65 p53 and histone H4 |
HDAC6 | 14-3-3ζ mDia2 CTTN | |
HDAC8 |
| p53 |
HDAC9 |
| |
SIRT1 | FOXO3 | |
SIRT3 |
| SOD2 |
SIRT6 |
| Histone H3 (K56) |
SIRT7 |
|
Funding
Institutional Review Board Statement
Informed Consent Statement
Conflicts of Interest
References
- Allfrey, V.G.; Faulkner, R.; Mirsky, A.E. Acetylation and Methylation of Histones and Their Possible role in the Regulation of RNA Synthesis. Proc. Natl. Acad. Sci. USA 1964, 51, 786–794. [Google Scholar] [CrossRef] [PubMed]
- Dowling, D.P.; Di Costanzo, L.; Gennadios, H.A.; Christianson, D.W. Evolution of the arginase fold and functional diversity. Cell. Mol. Life Sci. 2008, 65, 2039–2055. [Google Scholar] [CrossRef] [PubMed]
- Eberharter, A.; Becker, P.B. Histone acetylation: A switch between repressive and permissive chromatin. EMBO Rep. 2002, 3, 224–229. [Google Scholar] [CrossRef] [PubMed]
- Eberharter, A.; Ferreira, R.; Becker, P. Dynamic chromatin: Concerted nucleosome remodelling and acetylation. Biol. Chem. 2005, 386, 745–747. [Google Scholar] [CrossRef]
- Kuo, M.H.; Allis, C.D. Roles of histone acetyltransferases and deacetylases in gene regulation. Bioessays 1998, 20, 615–626. [Google Scholar] [CrossRef]
- Marmorstein, R. Structure of Histone Deacetylases: Insights into Substrate Recognition and Catalysis. Structure 2001, 9, 1127–1133. [Google Scholar] [CrossRef]
- Verdone, L.; Caserta, M.; Di Mauro, E. Role of histone acetylation in the control of gene expression. Biochem. Cell Biol. 2005, 83, 344–353. [Google Scholar] [CrossRef]
- Yang, W.-M.; Inouye, C.; Zeng, Y.; Bearss, D.; Seto, E. Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3. Proc. Natl. Acad. Sci. USA 1996, 93, 12845–12850. [Google Scholar] [CrossRef]
- Emiliani, S.; Fischle, W.; Van Lint, C.; Al-Abed, Y.; Verdin, E. Characterization of a human RPD3 ortholog, HDAC3. Proc. Natl. Acad. Sci. USA 1998, 95, 2795–2800. [Google Scholar] [CrossRef]
- Rundlett, S.E.; Carmen, A.A.; Kobayashi, R.; Bavykin, S.; Turner, B.M.; Grunstein, M. HDA1 and RPD3 are members of distinct yeast histone deacetylase complexes that regulate silencing and transcription. Proc. Natl. Acad. Sci. USA 1996, 93, 14503–14508. [Google Scholar] [CrossRef] [Green Version]
- Vannini, A.; Volpari, C.; Filocamo, G.; Casavola, E.C.; Brunetti, M.; Renzoni, D.; Chakravarty, P.; Paolini, C.; De Francesco, R.; Gallinari, P.; et al. Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor. Proc. Natl. Acad. Sci. USA 2004, 101, 15064–15069. [Google Scholar] [CrossRef] [PubMed]
- Finnin, M.S.; Donigian, J.R.; Cohen, A.; Richon, V.M.; Rifkind, R.A.; Marks, P.A.; Breslow, R.; Pavletich, N.P. Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature 1999, 401, 188–193. [Google Scholar] [CrossRef] [PubMed]
- Grozinger, C.M.; Hassig, C.A.; Schreiber, S.L. Three proteins define a class of human histone deacetylases related to yeast Hda1p. Proc. Natl. Acad. Sci. USA 1999, 96, 4868–4873. [Google Scholar] [CrossRef] [PubMed]
- Kao, H.-Y.; Downes, M.; Ordentlich, P.; Evans, R.M. Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression. Genes Dev. 2000, 14, 55–66. [Google Scholar] [CrossRef] [PubMed]
- Buggy, J.J.; Sideris, M.L.; Mak, P.; Lorimer, D.D.; Mcintosh, B.; Clark, J.M. Cloning and characterization of a novel human histone deacetylase, HDAC8. Biochem. J. 2000, 1, 199–205. [Google Scholar] [CrossRef]
- Zhou, X.; Marks, P.A.; Rifkind, R.A.; Richon, V.M. Cloning and characterization of a histone deacetylase, HDAC9. Proc. Natl. Acad. Sci. USA 2001, 98, 10572–10577. [Google Scholar] [CrossRef]
- Tong, J.J.; Liu, J.; Bertos, N.R.; Yang, X.-J. Identification of HDAC10, a novel class II human histone deacetylase containing a leucine-rich domain. Nucleic Acids Res. 2002, 30, 1114–1123. [Google Scholar] [CrossRef]
- Sengupta, N.; Seto, E. Regulation of histone deacetylase activities. J. Cell. Biochem. 2004, 93, 57–67. [Google Scholar] [CrossRef]
- Hsu, K.-C.; Liu, C.-Y.; Lin, T.E.; Hsieh, J.-H.; Sung, T.-Y.; Tseng, H.-J.; Yang, J.-M.; Huang, W.-J. Novel Class IIa-Selective Histone Deacetylase Inhibitors Discovered Using an in Silico Virtual Screening Approach. Sci. Rep. 2017, 7, 3228. [Google Scholar] [CrossRef]
- Luo, Z.; Qing, X.; Benda, C.; Huang, Z.; Zhang, M.; Huang, Y.; Zhang, H.; Wang, L.; Lai, Y.; Ward, C.; et al. Nuclear-cytoplasmic shuttling of class IIa histone deacetylases regulates somatic cell reprogramming. Cell Regen. 2019, 8, 21–29. [Google Scholar] [CrossRef]
- Tao, X.; Yan, Y.; Lu, L.; Chen, B. HDAC10 expression is associated with DNA mismatch repair gene and is a predictor of good prognosis in colon carcinoma. Oncol. Lett. 2017, 14, 4923–4929. [Google Scholar] [CrossRef] [PubMed]
- Liu, Y.; Peng, L.; Seto, E.; Huang, S.; Qiu, Y. Modulation of Histone Deacetylase 6 (HDAC6) Nuclear Import and Tubulin Deacetylase Activity through Acetylation. J. Biol. Chem. 2012, 287, 29168–29174. [Google Scholar] [CrossRef] [PubMed]
- Zhang, Y.; Kwon, S.; Yamaguchi, T.; Cubizolles, F.; Rousseaux, S.; Kneissel, M.; Cao, C.; Li, N.; Cheng, H.-L.; Chua, K.; et al. Mice Lacking Histone Deacetylase 6 Have Hyperacetylated Tubulin but Are Viable and Develop Normally. Mol. Cell. Biol. 2008, 28, 1688–1701. [Google Scholar] [CrossRef] [PubMed]
- Blander, G.; Guarente, L. The Sir2 Family of Protein Deacetylases. Annu. Rev. Biochem. 2004, 73, 417–435. [Google Scholar] [CrossRef]
- Houtkooper, R.H.; Cantó, C.; Wanders, R.J.; Auwerx, J. The Secret Life of NAD+: An Old Metabolite Controlling New Metabolic Signaling Pathways. Endocr. Rev. 2010, 31, 194–223. [Google Scholar] [CrossRef]
- Cosenza, M.; Pozzi, S. The Therapeutic Strategy of HDAC6 Inhibitors in Lymphoproliferative Disease. Int. J. Mol. Sci. 2018, 19, 2337. [Google Scholar] [CrossRef]
- Bagchi, D.; Nair, S. Nutritional and Therapeutic Interventions for Diabetes and Metabolic Syndrome; Academic Press: Cambridge, MA, USA, 2018. [Google Scholar]
- Cheng, F.; Lienlaf, M.; Perez-Villarroel, P.; Wang, H.-W.; Lee, C.; Woan, K.; Woods, D.; Knox, T.; Bergman, J.; Pinilla-Ibarz, J.; et al. Divergent roles of histone deacetylase 6 (HDAC6) and histone deacetylase 11 (HDAC11) on the transcriptional regulation of IL10 in antigen presenting cells. Mol. Immunol. 2014, 60, 44–53. [Google Scholar] [CrossRef]
- Lehrmann, H.; Pritchard, L.L.; Harel-Bellan, A. Histone acetyltransferases and deacetylases in the control of cell proliferation and differentiation. Adv. Cancer Res. 2002, 86, 41–65. [Google Scholar] [CrossRef]
- Mai, A.; Massa, S.; Rotili, D.; Cerbara, I.; Valente, S.; Pezzi, R.; Simeoni, S.; Ragno, R. Histone deacetylation in epigenetics: An attractive target for anticancer therapy. Med. Res. Rev. 2005, 25, 261–309. [Google Scholar] [CrossRef]
- Dupont, C.; Armant, D.R.; Brenner, C.A. Epigenetics: Definition, Mechanisms and Clinical Perspective. Semin. Reprod. Med. 2009, 27, 351–357. [Google Scholar] [CrossRef] [Green Version]
- Xu, W.S.; Parmigiani, R.B.; Marks, P.A. Histone deacetylase inhibitors: Molecular mechanisms of action. Oncogene 2007, 26, 5541–5552. [Google Scholar] [CrossRef] [PubMed]
- Carrier, F. Chromatin Modulation by Histone Deacetylase Inhibitors: Impact on Cellular Sensitivity to Ionizing Radiation. Mol. Cell. Pharmacol. 2013, 5, 51–59. [Google Scholar] [PubMed]
- Workman, J.L. Nucleosome displacement in transcription. Genes Dev. 2006, 20, 2009–2017. [Google Scholar] [CrossRef] [PubMed]
- Park, S.-Y.; Kim, J.-S. A short guide to histone deacetylases including recent progress on class II enzymes. Exp. Mol. Med. 2020, 52, 204–212. [Google Scholar] [CrossRef] [PubMed]
- Ehrenhofer-Murray, A.E. Chromatin dynamics at DNA replication, transcription and repair. Eur. J. Biochem. 2004, 271, 2335–2349. [Google Scholar] [CrossRef] [PubMed]
- Wade, P.A. Transcriptional control at regulatory checkpoints by histone deacetylases: Molecular connections between cancer and chromatin. Hum. Mol. Genet. 2001, 10, 693–698. [Google Scholar] [CrossRef]
- Strahl, B.D.; Allis, C.D. The language of covalent histone modifications. Nature 2000, 403, 41–45. [Google Scholar] [CrossRef]
- Yoshida, M.; Furumai, R.; Nishiyama, M.; Komatsu, Y.; Nishino, N.; Horinouchi, S. Histone deacetylase as a new target for cancer chemotherapy. Cancer Chemother. Pharmacol. 2001, 48, S20–S26. [Google Scholar] [CrossRef]
- Kurdistani, S.K.; Robyr, D.; Tavazoie, S.; Grunstein, M. Genome-wide binding map of the histone deacetylase Rpd3 in yeast. Nat. Genet. 2002, 31, 248–254. [Google Scholar] [CrossRef]
- Wang, A.; Kurdistani, S.K.; Grunstein, M. Requirement of Hos2 Histone Deacetylase for Gene Activity in Yeast. Science 2002, 298, 1412–1414. [Google Scholar] [CrossRef]
- Vidal, M.; Gaber, R.F. RPD3 encodes a second factor required to achieve maximum positive and negative transcriptional states in Saccharomyces cerevisiae. Mol. Cell. Biol. 1991, 11, 6317–6327. [Google Scholar] [PubMed]
- Vidal, M.; Strich, R.; Esposito, R.E.; Gaber, R.F. RPD1 (SIN3/UME4) is required for maximal activation and repression of diverse yeast genes. Mol. Cell. Biol. 1991, 11, 6306–6316. [Google Scholar]
- Chou, C.-W.; Wu, M.-S.; Huang, W.-C.; Chen, C.-C. HDAC Inhibition Decreases the Expression of EGFR in Colorectal Cancer Cells. PLoS ONE 2011, 6, e18087. [Google Scholar] [CrossRef] [PubMed]
- Kim, Y.J.; Greer, C.B.; Cecchini, K.R.; Harris, L.N.; Tuck, D.P.; Kim, T.H. HDAC inhibitors induce transcriptional repression of high copy number genes in breast cancer through elongation blockade. Oncogene 2013, 32, 2828–2835. [Google Scholar] [CrossRef] [PubMed]
- Scott, G.K.; Marden, C.; Xu, F.; Kirk, L.; Benz, C.C. Transcriptional repression of ErbB2 by histone deacetylase inhibitors detected by a genomically integrated ErbB2 promoter-reporting cell screen. Mol. Cancer Ther. 2002, 1, 385–392. [Google Scholar] [PubMed]
- Wang, Z.; Zang, C.; Cui, K.; Schones, D.E.; Barski, A.; Peng, W.; Zhao, K. Genome-wide Mapping of HATs and HDACs Reveals Distinct Functions in Active and Inactive Genes. Cell 2009, 138, 1019–1031. [Google Scholar] [CrossRef]
- Yoshida, M.; Kudo, N.; Kosono, S.; Ito, A. Chemical and structural biology of protein lysine deacetylases. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 2017, 93, 297–321. [Google Scholar] [CrossRef]
- Peng, L.; Seto, E. Deacetylation of Nonhistone Proteins by HDACs and the Implications in Cancer. Handb. Exp. Pharmacol. 2011, 206, 39–56. [Google Scholar] [CrossRef]
- Zhang, J.; Sprung, R.; Pei, J.; Tan, X.; Kim, S.; Zhu, H.; Liu, C.F.; Grishin, N.V.; Zhao, Y. Lysine Acetylation Is a Highly Abundant and Evolutionarily Conserved Modification in Escherichia Coli. Mol. Cell. Proteom. 2009, 8, 215–225. [Google Scholar] [CrossRef]
- Reed, S.M.; Quelle, D.E. p53 Acetylation: Regulation and Consequences. Cancers 2014, 7, 30–69. [Google Scholar] [CrossRef]
- Liu, L.; Scolnick, D.M.; Trievel, R.C.; Zhang, H.B.; Marmorstein, R.; Halazonetis, T.D.; Berger, S.L. p53 Sites Acetylated In Vitro by PCAF and p300 Are Acetylated In Vivo in Response to DNA Damage. Mol. Cell. Biol. 1999, 19, 1202–1209. [Google Scholar] [CrossRef] [Green Version]
- Tang, Y.; Luo, J.; Zhang, W.; Gu, W. Tip60-Dependent Acetylation of p53 Modulates the Decision between Cell-Cycle Arrest and Apoptosis. Mol. Cell 2006, 24, 827–839. [Google Scholar] [CrossRef]
- Gu, W.; Roeder, R.G. Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain. Cell 1997, 90, 595–606. [Google Scholar] [CrossRef]
- Legube, G.; Linares, L.K.; Tyteca, S.; Caron, C.; Scheffner, M.; Chevillard-Briet, M.; Trouche, D. Role of the Histone Acetyl Transferase Tip60 in the p53 Pathway. J. Biol. Chem. 2004, 279, 44825–44833. [Google Scholar] [CrossRef]
- Dohmesen, C.; Koeppel, M.; Dobbelstein, M. Specific inhibition of Mdm2-mediated neddylation by Tip60. Cell Cycle 2008, 7, 222–231. [Google Scholar] [CrossRef]
- Subramanian, C.; Jarzembowski, J.A.; Opipari, A.W.; Castle, V.P.; Kwok, R.P. HDAC6 Deacetylates Ku70 and Regulates Ku70-Bax Binding in Neuroblastoma. Neoplasia 2011, 13, 726–734. [Google Scholar] [CrossRef]
- Yeung, F.; Hoberg, J.E.; Ramsey, C.S.; Keller, M.D.; Jones, D.R.; Frye, R.A.; Mayo, M.W. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 2004, 23, 2369–2380. [Google Scholar] [CrossRef]
- Faiola, F.; Liu, X.; Lo, S.; Pan, S.; Zhang, K.; Lymar, E.; Farina, A.; Martinez, E. Dual Regulation of c-Myc by p300 via Acetylation-Dependent Control of Myc Protein Turnover and Coactivation of Myc-Induced Transcription. Mol. Cell. Biol. 2005, 25, 10220–10234. [Google Scholar] [CrossRef]
- Verdel, A.; Curtet, S.; Brocard, M.P.; Rousseaux, S.; Lemercier, C.; Yoshida, M.; Khochbin, S. Active maintenance of mHDA2/mHDAC6 histone-deacetylase in the cytoplasm. Curr. Biol. 2000, 10, 747–749. [Google Scholar] [CrossRef]
- Kawaguchi, Y.; Kovacs, J.J.; McLaurin, A.; Vance, J.M.; Ito, A.; Yao, T.-P. The Deacetylase HDAC6 Regulates Aggresome Formation and Cell Viability in Response to Misfolded Protein Stress. Cell 2003, 115, 727–738. [Google Scholar] [CrossRef]
- Zhang, X.; Yuan, Z.; Zhang, Y.; Yong, S.; Salas-Burgos, A.; Koomen, J.; Olashaw, N.; Parsons, J.T.; Yang, X.-J.; Dent, S.R.; et al. HDAC6 Modulates Cell Motility by Altering the Acetylation Level of Cortactin. Mol. Cell 2007, 27, 197–213. [Google Scholar] [CrossRef] [Green Version]
- Boyault, C.; Zhang, Y.; Fritah, S.; Caron, C.; Gilquin, B.; Kwon, S.H.; Garrido, C.; Yao, T.-P.; Vourc’H, C.; Matthias, P.; et al. HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates. Genes Dev. 2007, 21, 2172–2181. [Google Scholar] [CrossRef]
- Xu, Z.; Schaedel, L.; Portran, D.; Aguilar, A.; Gaillard, J.; Marinkovich, M.P.; Théry, M.; Nachury, M.V. Microtubules acquire resistance from mechanical breakage through intralumenal acetylation. Science 2017, 356, 328–332. [Google Scholar] [CrossRef]
- Reed, N.A.; Cai, D.; Blasius, T.L.; Jih, G.T.; Meyhofer, E.; Gaertig, J.; Verhey, K.J. Microtubule Acetylation Promotes Kinesin-1 Binding and Transport. Curr. Biol. 2006, 16, 2166–2172. [Google Scholar] [CrossRef]
- Dompierre, J.P.; Godin, J.D.; Charrin, B.C.; Cordelières, F.P.; King, S.J.; Humbert, S.; Saudou, F. Histone Deacetylase 6 Inhibition Compensates for the Transport Deficit in Huntington’s Disease by Increasing Tubulin Acetylation. J. Neurosci. 2007, 27, 3571–3583. [Google Scholar] [CrossRef]
- Giustiniani, J.; Daire, V.; Cantaloube, I.; Durand, G.; Poüs, C.; Perdiz, D.; Baillet, A. Tubulin acetylation favors Hsp90 recruitment to microtubules and stimulates the signaling function of the Hsp90 clients Akt/PKB and p53. Cell. Signal. 2009, 21, 529–539. [Google Scholar] [CrossRef]
- Sudo, H.; Baas, P.W. Acetylation of Microtubules Influences Their Sensitivity to Severing by Katanin in Neurons and Fibroblasts. J. Neurosci. 2010, 30, 7215–7226. [Google Scholar] [CrossRef]
- Cosen-Binker, L.I.; Kapus, A. Cortactin: The Gray Eminence of the Cytoskeleton. Physiology 2006, 21, 352–361. [Google Scholar] [CrossRef]
- Thon, J.N.; Italiano, J.E. Platelet formation. Semin. Hematol. 2010, 47, 220–226. [Google Scholar] [CrossRef]
- Machlus, K.R.; Thon, J.N.; Italiano, J.E. Interpreting the developmental dance of the megakaryocyte: A review of the cellular and molecular processes mediating platelet formation. Br. J. Haematol. 2014, 165, 227–236. [Google Scholar] [CrossRef]
- Poulter, N.S.; Thomas, S.G. Cytoskeletal regulation of platelet formation: Coordination of F-actin and microtubules. Int. J. Biochem. Cell Biol. 2015, 66, 69–74. [Google Scholar] [CrossRef] [PubMed]
- Antkowiak, A.; Viaud, J.; Severin, S.; Zanoun, M.; Ceccato, L.; Chicanne, G.; Strassel, C.; Eckly, A.; Leon, C.; Gachet, C.; et al. Cdc42-dependent F-actin dynamics drive structuration of the demarcation membrane system in megakaryocytes. J. Thromb. Haemost. 2016, 14, 1268–1284. [Google Scholar] [CrossRef] [PubMed]
- Italiano, J.E., Jr.; Lécine, P.; Shivdasani, R.A.; Hartwig, J.H. Blood Platelets Are Assembled Principally at the Ends of Proplatelet Processes Produced by Differentiated Megakaryocytes. J. Cell Biol. 1999, 147, 1299–1312. [Google Scholar] [CrossRef] [PubMed]
- Messaoudi, K.; Ali, A.; Ishaq, R.; Palazzo, A.; Sliwa, D.; Bluteau, O.; Souquère, S.; Muller, D.; Diop, K.M.; Rameau, P.; et al. Critical role of the HDAC6–cortactin axis in human megakaryocyte maturation leading to a proplatelet-formation defect. Nat. Commun. 2017, 8, 1786. [Google Scholar] [CrossRef]
- Wada, T.; Kikuchi, J.; Nishimura, N.; Shimizu, R.; Kitamura, T.; Furukawa, Y. Expression Levels of Histone Deacetylases Determine the Cell Fate of Hematopoietic Progenitors. J. Biol. Chem. 2009, 284, 30673–30683. [Google Scholar] [CrossRef]
- Elizalde, C.; Fernández-Rueda, J.; Salcedo, J.M.; Dorronsoro, A.; Ferrin, I.; Jakobsson, E.; Trigueros, C. Histone Deacetylase 3 Modulates the Expansion of Human Hematopoietic Stem Cells. Stem Cells Dev. 2012, 21, 2581–2591. [Google Scholar] [CrossRef]
- Ozawa, Y.; Towatari, M.; Tsuzuki, S.; Hayakawa, F.; Maeda, T.; Miyata, Y.; Tanimoto, M.; Saito, H. Histone deacetylase 3 associates with and represses the transcription factor GATA-2. Blood 2001, 98, 2116–2123. [Google Scholar] [CrossRef]
- Summers, A.R.; Fischer, M.A.; Stengel, K.R.; Zhao, Y.; Kaiser, J.F.; Wells, C.E.; Hunt, A.; Bhaskara, S.; Luzwick, J.W.; Sampathi, S.; et al. HDAC3 is essential for DNA replication in hematopoietic progenitor cells. J. Clin. Investig. 2013, 123, 3112–3123. [Google Scholar] [CrossRef]
- Bertrand, J.Y.; Chi, N.C.; Santoso, B.; Teng, S.; Stainier, D.Y.; Traver, D. Haematopoietic stem cells derive directly from aortic endothelium during development. Nature 2010, 464, 108–111. [Google Scholar] [CrossRef]
- Wei, Y.; Ma, D.; Gao, Y.; Zhang, C.; Wang, L.; Liu, F. Ncor2 is required for hematopoietic stem cell emergence by inhibiting Fos signaling in zebrafish. Blood 2014, 124, 1578–1585. [Google Scholar] [CrossRef]
- Hua, W.-K.; Qi, J.; Cai, Q.; Carnahan, E.; Ramirez, M.A.; Li, L.; Marcucci, G.; Kuo, Y.-H. HDAC8 regulates long-term hematopoietic stem-cell maintenance under stress by modulating p53 activity. Blood 2017, 130, 2619–2630. [Google Scholar] [CrossRef] [PubMed]
- Chute, J.P. Stem cell homing. Curr. Opin. Hematol. 2006, 13, 399–406. [Google Scholar] [CrossRef] [PubMed]
- Huang, X.; Guo, B.; Liu, S.; Wan, J.; Broxmeyer, H.E. Neutralizing negative epigenetic regulation by HDAC5 enhances human haematopoietic stem cell homing and engraftment. Nat. Commun. 2018, 9, 2741. [Google Scholar] [CrossRef] [PubMed]
- Roth, M.; Wang, Z.; Chen, W.Y. Sirtuins in hematological aging and malignancy. Crit. Rev. Oncog. 2013, 18, 531–547. [Google Scholar] [CrossRef]
- Rimmelé, P.; Bigarella, C.L.; Liang, R.; Izac, B.; Dieguez-Gonzalez, R.; Barbet, G.; Donovan, M.; Brugnara, C.; Blander, J.M.; Sinclair, D.A.; et al. Aging-like Phenotype and Defective Lineage Specification in SIRT1-Deleted Hematopoietic Stem and Progenitor Cells. Stem Cell Rep. 2014, 3, 44–59. [Google Scholar] [CrossRef]
- Brown, K.; Xie, S.; Qiu, X.; Mohrin, M.; Shin, J.; Liu, Y.; Zhang, D.; Scadden, D.T.; Chen, D. SIRT3 Reverses Aging-Associated Degeneration. Cell Rep. 2013, 3, 319–327. [Google Scholar] [CrossRef]
- Wang, H.; Diao, D.; Shi, Z.; Zhu, X.; Gao, Y.; Gao, S.; Liu, X.; Wu, Y.; Rudolph, K.L.; Liu, G.-H.; et al. SIRT6 Controls Hematopoietic Stem Cell Homeostasis through Epigenetic Regulation of Wnt Signaling. Cell Stem Cell 2016, 18, 495–507. [Google Scholar] [CrossRef]
- Mohrin, M.; Shin, J.; Liu, Y.; Brown, K.; Luo, H.; Xi, Y.; Haynes, C.M.; Chen, D. A mitochondrial UPR-mediated metabolic checkpoint regulates hematopoietic stem cell aging. Science 2015, 347, 1374–1377. [Google Scholar] [CrossRef]
- Yamamura, K.; Ohishi, K.; Katayama, N.; Yu, Z.; Kato, K.; Masuya, M.; Fujieda, A.; Sugimoto, Y.; Miyata, E.; Shibasaki, T.; et al. Pleiotropic role of histone deacetylases in the regulation of human adult erythropoiesis. Br. J. Haematol. 2006, 135, 242–253. [Google Scholar] [CrossRef]
- Bottardi, S.; Ross, J.; Bourgoin, V.; Fotouhi-Ardakani, N.; Affar, E.B.; Trudel, M.; Milot, E. Ikaros and GATA-1 combinatorial effect is required for silencing of human gamma-globin genes. Mol. Cell. Biol. 2009, 29, 1526–1537. [Google Scholar] [CrossRef]
- Zhao, Q.; Cumming, H.; Cerruti, L.; Cunningham, J.M.; Jane, S.M. Site-specific Acetylation of the Fetal Globin Activator NF-E4 Prevents Its Ubiquitination and Regulates Its Interaction with the Histone Deacetylase, HDAC1. J. Biol. Chem. 2004, 279, 41477–41486. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mankidy, R.; Faller, D.V.; Mabaera, R.; Lowrey, C.H.; Boosalis, M.S.; White, G.L.; Castaneda, S.A.; Perrine, S.P. Short-chain fatty acids induce gamma-globin gene expression by displacement of a HDAC3-NCoR repressor complex. Blood 2006, 108, 3179–3186. [Google Scholar] [CrossRef] [PubMed]
- Pasricha, S.-R.; Lim, P.J.; Duarte, T.L.; Casu, C.; Oosterhuis, D.; Mleczko-Sanecka, K.; Suciu, M.; Da Silva, A.R.; Al-Hourani, K.; Arezes, J.; et al. Hepcidin is regulated by promoter-associated histone acetylation and HDAC3. Nat. Commun. 2017, 8, 403. [Google Scholar] [CrossRef]
- Muralidhar, S.A.; Ramakrishnan, V.; Kalra, I.S.; Li, W.; Pace, B.S. Histone deacetylase 9 activates gamma-globin gene expression in primary erythroid cells. J. Biol. Chem. 2011, 286, 2343–2353. [Google Scholar] [CrossRef]
- Wilting, R.H.; Yanover, E.; Heideman, M.R.; Jacobs, H.; Horner, J.; Van Der Torre, J.; DePinho, R.; Dannenberg, J.-H. Overlapping functions of Hdac1 and Hdac2 in cell cycle regulation and haematopoiesis. EMBO J. 2010, 29, 2586–2597. [Google Scholar] [CrossRef] [PubMed]
- Kim, M.Y.; Yan, B.; Huang, S.; Qiu, Y. Regulating the Regulators: The Role of Histone Deacetylase 1 (HDAC1) in Erythropoiesis. Int. J. Mol. Sci. 2020, 21, 8460. [Google Scholar] [CrossRef] [PubMed]
- Wang, P.; Wang, Z.; Liu, J. Role of HDACs in normal and malignant hematopoiesis. Mol. Cancer 2020, 19, 5. [Google Scholar] [CrossRef] [PubMed]
- Chen, X.; Bieker, J.J. Stage-Specific Repression by the EKLF Transcriptional Activator. Mol. Cell. Biol. 2004, 24, 10416–10424. [Google Scholar] [CrossRef] [PubMed]
- Zhang, W.; Kadam, S.; Emerson, B.M.; Bieker, J.J. Site-specific acetylation by p300 or CREB binding protein regulates erythroid Krüppel-like factor transcriptional activity via its interaction with the SWI-SNF complex. Mol. Cell. Biol. 2001, 21, 2413–2422. [Google Scholar] [CrossRef]
- Suzuki, M.; Yamada, T.; Kihara-Negishi, F.; Sakurai, T.; Oikawa, T. Direct association between PU.1 and MeCP2 that recruits mSin3A-HDAC complex for PU.1-mediated transcriptional repression. Oncogene 2003, 22, 8688–8698. [Google Scholar] [CrossRef]
- Yang, T.; Jian, W.; Luo, Y.; Fu, X.; Noguchi, C.; Bungert, J.; Huang, S.; Qiu, Y. Acetylation of Histone Deacetylase 1 Regulates NuRD Corepressor Complex Activity. J. Biol. Chem. 2012, 287, 40279–40291. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Laurent, B.; Randrianarison-Huetz, V.; Frisan, E.; Andrieu-Soler, C.; Soler, E.; Fontenay, M.; Dusanter-Fourt, I.; Duménil, D. A short Gfi-1B isoform controls erythroid differentiation by recruiting the LSD1–CoREST complex through the dimethylation of its SNAG domain. J. Cell Sci. 2012, 125, 993–1002. [Google Scholar] [CrossRef] [PubMed]
- Yan, B.; Yang, J.; Kim, M.Y.; Luo, H.; Cesari, N.; Yang, T.; Strouboulis, J.; Zhang, J.; Hardison, R.; Huang, S.; et al. HDAC1 is required for GATA-1 transcription activity, global chromatin occupancy and hematopoiesis. Nucleic Acids Res. 2021, 49, 9783–9798. [Google Scholar] [CrossRef] [PubMed]
- Blobel, G.A.; Nakajima, T.; Eckner, R.; Montminy, M.; Orkin, S.H. CREB-binding protein cooperates with transcription factor GATA-1 and is required for erythroid differentiation. Proc. Natl. Acad. Sci. USA 1998, 95, 2061–2066. [Google Scholar] [CrossRef]
- Hung, H.-L.; Lau, J.; Kim, A.Y.; Weiss, M.J.; Blobel, G.A. CREB-Binding Protein Acetylates Hematopoietic Transcription Factor GATA-1 at Functionally Important Sites. Mol. Cell. Biol. 1999, 19, 3496–3505. [Google Scholar] [CrossRef]
- Lamonica, J.M.; Deng, W.; Kadauke, S.; Campbell, A.E.; Gamsjaeger, R.; Wang, H.; Cheng, Y.; Billin, A.N.; Hardison, R.C.; Mackay, J.P.; et al. Bromodomain protein Brd3 associates with acetylated GATA1 to promote its chromatin occupancy at erythroid target genes. Proc. Natl. Acad. Sci. USA 2011, 108, E159–E168. [Google Scholar] [CrossRef]
- Jian, W.; Yan, B.; Huang, S.; Qiu, Y. Histone deacetylase 1 activates PU.1 gene transcription through regulating TAF9 deacetylation and transcription factor IID assembly. FASEB J. 2017, 31, 4104–4116. [Google Scholar] [CrossRef]
- Willcockson, M.A.; Taylor, S.J.; Ghosh, S.; Healton, S.E.; Wheat, J.C.; Wilson, T.J.; Steidl, U.; Skoultchi, A.I. Runx1 promotes murine erythroid progenitor proliferation and inhibits differentiation by preventing Pu.1 downregulation. Proc. Natl. Acad. Sci. USA 2019, 116, 17841–17847. [Google Scholar] [CrossRef]
- Pop, R.; Shearstone, J.R.; Shen, Q.; Liu, Y.; Hallstrom, K.; Koulnis, M.; Gribnau, J.; Socolovsky, M. A Key Commitment Step in Erythropoiesis Is Synchronized with the Cell Cycle Clock through Mutual Inhibition between PU.1 and S-Phase Progression. PLOS Biol. 2010, 8, e1000484. [Google Scholar] [CrossRef]
- Ji, P.; Yeh, V.; Ramirez, T.; Murata-Hori, M.; Lodish, H.F. Histone deacetylase 2 is required for chromatin condensation and subsequent enucleation of cultured mouse fetal erythroblasts. Haematologica 2010, 95, 2013–2021. [Google Scholar] [CrossRef]
- Watamoto, K.; Towatari, M.; Ozawa, Y.; Miyata, Y.; Okamoto, M.; Abe, A.; Naoe, T.; Saito, H. Altered interaction of HDAC5 with GATA-1 during MEL cell differentiation. Oncogene 2003, 22, 9176–9184. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Delehanty, L.L.; Bullock, G.C.; Goldfarb, A.N. Protein kinase D-HDAC5 signaling regulates erythropoiesis and contributes to erythropoietin cross-talk with GATA1. Blood 2012, 120, 4219–4228. [Google Scholar] [CrossRef] [PubMed]
- Varricchio, L.; Dell’Aversana, C.; Nebbioso, A.; Migliaccio, G.; Altucci, L.; Mai, A.; Grazzini, G.; Bieker, J.J.; Migliaccio, A.R. Identification of NuRSERY, a new functional HDAC complex composed by HDAC5, GATA1, EKLF and pERK present in human erythroid cells. Int. J. Biochem. Cell Biol. 2014, 50, 112–122. [Google Scholar] [CrossRef] [PubMed]
- Wang, Y.; Li, W.; Schulz, V.P.; Zhao, H.; Qu, X.; Qi, Q.; Cheng, Y.; Guo, X.; Zhang, S.; Wei, X.; et al. Impairment of human terminal erythroid differentiation by histone deacetylase 5 deficiency. Blood 2021, 138, 1615–1627. [Google Scholar] [CrossRef] [PubMed]
- Li, X.; Mei, Y.; Yan, B.; Vitriol, E.; Huang, S.; Ji, P.; Qiu, Y. Histone deacetylase 6 regulates cytokinesis and erythrocyte enucleation through deacetylation of formin protein mDia2. Haematologica 2017, 102, 984–994. [Google Scholar] [CrossRef] [PubMed]
- Watanabe, S.; De Zan, T.; Ishizaki, T.; Yasuda, S.; Kamijo, H.; Yamada, D.; Aoki, T.; Kiyonari, H.; Kaneko, H.; Shimizu, R.; et al. Loss of a Rho-Regulated Actin Nucleator, mDia2, Impairs Cytokinesis during Mouse Fetal Erythropoiesis. Cell Rep. 2013, 5, 926–932. [Google Scholar] [CrossRef]
- Vogl, D.T.; Raje, N.; Jagannath, S.; Richardson, P.; Hari, P.; Orlowski, R.; Supko, J.G.; Tamang, D.; Yang, M.; Jones, S.S.; et al. Ricolinostat, the First Selective Histone Deacetylase 6 Inhibitor, in Combination with Bortezomib and Dexa-methasone for Relapsed or Refractory Multiple Myeloma. Clin. Cancer Res. 2017, 23, 3307–3315. [Google Scholar] [CrossRef]
- Raje, N.S.; Bensinger, W.; Cole, C.E.; Lonial, S.; Jagannath, S.; Arce-Lara, C.E.; Valent, J.; Rosko, A.E.; Harb, W.A.; Sandhu, I.; et al. Ricolinostat (ACY-1215), the First Selective HDAC6 Inhibitor, Combines Safely with Pomalidomide and Dexamethasone and Shows Promosing Early Results in Relapsed-and-Refractory Myeloma (ACE-MM-102 Study). Blood 2015, 126, 4228. [Google Scholar] [CrossRef]
- Raje, N.; Vogl, D.T.; Hari, P.N.; Jagannath, S.; Jones, S.S.; Supko, J.G.; Leone, R.G.; Wheeler, C.; Orlowski, M.R.Z.; Richardson, P.G.; et al. ACY-1215, a Selective Histone Deacetylase (HDAC) 6 Inhibitor: Interim Results Of Combination Therapy With Bortezomib In Patients With Multiple Myeloma (MM). Blood 2013, 122, 759. [Google Scholar] [CrossRef]
- Vogl, D.T.; Raje, N.; Hari, M.P.; Jones, S.S.; Supko, J.G.; Leone, R.G.; Wheeler, C.; Orlowski, R.Z.; Richardson, P.G.; Lonial, S.; et al. Phase 1B Results of Ricolinostat (ACY-1215) Combination Therapy with Bortezomib and Dexamethasone in Patients with Relapsed or Relapsed and Refractory Multiple Myeloma (MM). Blood 2014, 124, 4764. [Google Scholar] [CrossRef]
- Niesvizky, R.; Richardson, P.G.; Yee, A.J.; Nooka, A.K.; Raab, M.S.; Shain, K.H.; Gabrail, N.Y.; Matous, J.; Agarwal, A.B.; Hoffman, J.; et al. Selective HDAC6 Inhibitor ACY-241, an Oral Tablet, Combined with Pomalidomide and Dexamethasone: Safety and Efficacy of Escalation and Expansion Cohorts in Patients with Relapsed or Relapsed-and-Refractory Multiple Myeloma (ACE-MM-200 Study). Blood 2016, 128, 3307. [Google Scholar] [CrossRef]
- Lee, E.; Tan-Wasielewski, Z.; Matulonis, U.A.; Birrer, M.J.; Wright, A.A.; Horowitz, N.; Konstantinopoulos, P.A.; Curtis, J.; Liu, J.F. Results of an abbreviated Phase Ib study of the HDAC6 inhibitor ricolinostat and paclitaxel in recurrent ovarian, fallopian tube, or primary peritoneal cancer. Gynecol. Oncol. Rep. 2019, 29, 118–122. [Google Scholar] [CrossRef] [PubMed]
- Gordon, M.S.; Shapiro, G.; Sarantopoulos, J.; Juric, D.; Lu, B.; Chen, P.; Connarn, J.; Le Bruchec, Y.; Harvey, R.D. A phase 1b study of the safety, pharmacokinetics, and preliminary antitumor activity of citarinostat (ACY-241) in combination with paclitaxel (Pac) in patients (pts) with advanced solid tumors (AST). J. Clin. Oncol. 2018, 36, 2547. [Google Scholar] [CrossRef]
- Amengual, J.E.; Lue, J.K.; Ma, H.; Lichtenstein, R.; Shah, B.; Cremers, S.; Jones, S.; Sawas, A. First-in-Class Selective HDAC6 Inhibitor (ACY-1215) Has a Highly Favorable Safety Profile in Patients with Relapsed and Refractory Lymphoma. Oncologist 2021, 26, 184-e366. [Google Scholar] [CrossRef]
- Vong, P.; Messaoudi, K.; Jankovsky, N.; Caulier, A.; Demont, Y.; Boyer, T.; Marolleau, J.-P.; Rochette, J.; Haddou, H.H.; Garcon, L. P1404: Hdac6 regulates human erythroid differentiation through modulation of jak2 signaling. HemaSphere 2022, 6, 1288–1289. [Google Scholar] [CrossRef]
- McMullin, M.F.; Cario, H. LNK mutations and myeloproliferative disorders. Am. J. Hematol. 2016, 91, 248–251. [Google Scholar] [CrossRef]
- Gery, S.; Cao, Q.; Gueller, S.; Xing, H.; Tefferi, A.; Koeffler, H.P. Lnk inhibits myeloproliferative disorder-associated JAK2 mutant, JAK2V617F. J. Leukoc. Biol. 2009, 85, 957–965. [Google Scholar] [CrossRef]
- Yue, L.; Sharma, V.; Horvat, N.; Akuffo, A.A.; Beatty, M.S.; Murdun, C.; Colin, C.; Billington, J.M.R.; Goodheart, W.E.; Sahakian, E.; et al. HDAC11 deficiency disrupts oncogene-induced hematopoiesis in myeloproliferative neoplasms. Blood 2020, 135, 191–207. [Google Scholar] [CrossRef]
- Heideman, M.R.; Lancini, C.; Proost, N.; Yanover, E.; Jacobs, H.; Dannenberg, J.-H. Sin3a-associated Hdac1 and Hdac2 are essential for hematopoietic stem cell homeostasis and contribute differentially to hematopoiesis. Haematologica 2014, 99, 1292–1303. [Google Scholar] [CrossRef]
- Saleque, S.; Kim, J.; Rooke, H.M.; Orkin, S.H. Epigenetic Regulation of Hematopoietic Differentiation by Gfi-1 and Gfi-1b Is Mediated by the Cofactors CoREST and LSD1. Mol. Cell 2007, 27, 562–572. [Google Scholar] [CrossRef]
HDAC Class | Human Protein | Cellular Localization | Cofactor |
---|---|---|---|
Class I | HDAC1 | Nucleus | Zn2+ |
HDAC2 | Nucleus | ||
HDAC3 | Nucleus/Cytoplasm | ||
HDAC8 | Nucleus | ||
Class IIa | HDAC4 | Nuc leus/Cytoplasm | Zn2+ |
HDAC5 | Nucleus/Cytoplasm | ||
HDAC7 | Nucleus/Cytoplasm | ||
HDAC9 | Nucleus/Cytoplasm | ||
Class IIb | HDAC6 | Nucleus/Cytoplasm | Zn2+ |
HDAC10 | Nucleus/Cytoplasm | ||
Class III | SIRT1 | Nucleus | NAD+ |
SIRT2 | Cytoplasm | ||
SIRT3 | Mitochondria | ||
SIRT4 | Mitochondria | ||
SIRT5 | Mitochondria | ||
SIRT6 | Nucleus | ||
SIRT7 | Nucleus | ||
Class IV | HDAC11 | Nucleus/Cytoplasm | Zn2+ |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Vong, P.; Ouled-Haddou, H.; Garçon, L. Histone Deacetylases Function in the Control of Early Hematopoiesis and Erythropoiesis. Int. J. Mol. Sci. 2022, 23, 9790. https://doi.org/10.3390/ijms23179790
Vong P, Ouled-Haddou H, Garçon L. Histone Deacetylases Function in the Control of Early Hematopoiesis and Erythropoiesis. International Journal of Molecular Sciences. 2022; 23(17):9790. https://doi.org/10.3390/ijms23179790
Chicago/Turabian StyleVong, Pascal, Hakim Ouled-Haddou, and Loïc Garçon. 2022. "Histone Deacetylases Function in the Control of Early Hematopoiesis and Erythropoiesis" International Journal of Molecular Sciences 23, no. 17: 9790. https://doi.org/10.3390/ijms23179790